Aplastic anemia and Plasmacytoma

Summary:

Plasmacytoma is reported only by a few people with Aplastic anemia.

The study analyzes which people have Plasmacytoma with Aplastic anemia. It is created by eHealthMe based on 4 people who have Plasmacytoma and Aplastic anemia from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 27, 2023

4 people who have Aplastic Anemia and Plasmacytoma are studied.

What is Aplastic anemia?

Aplastic anemia is found to be associated with 1,402 drugs and 837 conditions by eHealthMe.

What is Plasmacytoma?

Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)) is found to be associated with 660 drugs and 221 conditions by eHealthMe.

Number of Plasmacytoma in Aplastic anemia reports submitted per year:

Would you have Plasmacytoma when you have Aplastic anemia?

Gender of people who have Aplastic Anemia and experienced Plasmacytoma *:

female: 100 %
male: 0.0 %

Age of people who have Aplastic Anemia and experienced Plasmacytoma *:

Common drugs taken by these people *:

Neoral: 3 people, 75.00%
Ciclosporin: 1 person, 25.00%

Common symptoms for these people *:

General Physical Health Deterioration (weak health status): 3 people, 75.00%
Plasma Cells Increased: 1 person, 25.00%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 25.00%
Hepatic Function Abnormal: 1 person, 25.00%
Fever: 1 person, 25.00%
Fatigue (feeling of tiredness): 1 person, 25.00%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 1 person, 25.00%
Disease Progression: 1 person, 25.00%
Blood Immunoglobulin M Increased: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Plasmacytoma?

Check whether Plasmacytoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Aplastic anemia (12,997 reports)
Plasmacytoma (4,029 reports)

COVID vaccines that are related to Plasmacytoma:

Common drugs associated with Plasmacytoma:

All the drugs that are associated with Plasmacytoma:

Plasmacytoma (660 drugs)

Common conditions associated with Plasmacytoma:

Multiple myeloma: 1,294 reports

All the conditions that are associated with Plasmacytoma:

Plasmacytoma (221 conditions)

How the study uses the data?

The study is based on Plasmacytoma and Aplastic anemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.